Skip to main content
SpringerLink
Log in

Antineoplastic drugs

Various toxicities and lack of efficacy: 6 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Zhao K, et al. [Efficacy and safety of Camrelizumab and AVD in the first-line treatment of classic Hodgkin's lymphoma]. [Chinese]. Zhonghua Xue Ye Xue Za Zhi 43: 431-434, No. 5, 14 May 2022. Available from: URL: http://doi.org/10.3760/cma.j.issn.0253-2727.2022.05.015 [Chinese; summarised from a translation]

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antineoplastic drugs. Reactions Weekly 1916, 40 (2022). https://doi.org/10.1007/s40278-022-19499-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-19499-8

Search

Navigation